Eicosanoid Biosynthesis

Eicosanoid Biosynthesis is the lipid metabolic pathway in which 20-carbon polyunsaturated fatty acids, primarily arachidonic acid, are enzymatically oxygenated by cyclooxygenases, lipoxygenases, and cytochrome P450 monooxygenases to generate bioactive eicosanoid mediators such as prostaglandins, thromboxanes, leukotrienes, and related oxidized derivatives.

14.4K

Publications

830.4K

Citations

41K

Authors

5K

Institutions

Publications per year

2017–2026

1K

Authors

41K

  1. BS
    Bengt Samuelsson

    Karolinska Institutet, Sweden

    134 publications · 22.9K citations

    80

    h-index

  2. JR
    John R. Falck

    The University of Texas Southwestern Medical Center, United States

    178 publications · 13.1K citations

    68

    h-index

  3. CN
    Charles N. Serhan

    Brigham and Women's Hospital, United States

    71 publications · 12.6K citations

    48

    h-index

  4. DC
    Darryl C. Zeldin

    National Institute of Environmental Health Sciences, United States

    78 publications · 6.8K citations

    47

    h-index

  5. MH
    Mats Hámberg

    Karolinska Institutet, Sweden

    91 publications · 14.1K citations

    46

    h-index

1–5 of 41K

Venues

  1. Journal of Biological Chemistry

    JBC · 748 publications · 88.1K citations

    160

    h-index

  2. Proceedings of the National Academy of Sciences

    PNAS · 187 publications · 47.2K citations

    117

    h-index

  3. PubMed

    Repository · 786 publications · 33.5K citations

    83

    h-index

  4. Biochemical and Biophysical Research Communications

    BBRC · 362 publications · 20.8K citations

    81

    h-index

  5. Journal of Clinical Investigation

    JCI · 124 publications · 21.2K citations

    78

    h-index

1–5